Richard MacIsaac
St Vincent's Hospital, VIC, Australia
- This delegate is presenting an abstract at this event.
Richard MacIsaac is professor and director of Endocrinology and Diabetes at St Vincent’s Hospital and the University of Melbourne. Prior to taking up his current position he was head of diabetes at Austin Health. His main research interest is diabetes and its complications, especially those related to cardiovascular and kidney disease. He has published over 170 research articles. Prior to embarking in a career in medicine, he completed a PhD at the Howard Florey Institute, Melbourne where he examined the development of the foetal hypothalamic-pituitary-adrenal axis and then embarked on a 2-year post doctorial fellowship at St Vincent’s Institute of Medical Research, Melbourne examining foetal calcium metabolism. He graduated from the University of Melbourne’s Medical School in 1995 and was awarded his fellowship with the Royal Australasian College of Physicians in 2002. Currently specific research interests are inpatient glycaemic control, defining the albuminuria and glomerular filtration rate relationship in diabetes, investigating new biomarkers for renal and vascular disease in diabetes and studying renal function in indigenous Australians.
Presentations this author is a contributor to:
Evaluation of Closed Loop Performance in Adults with Type 1 Diabetes Undertaking Anaerobic Versus Aerobic Exercise: A Randomised Crossover Study (#82)
8:45 AM
Dilshani Jayawardene
ADS President's Clinical Young Investigator Award
Trajectories of eGFR decline over a four year period: the eGFR Follow-up Study (#32)
11:30 AM
Federica Barzi
ADS Clinical Orals - Renal & Foot Complications
Exercise capacity (VO2max) is reduced in Type 2 diabetes mellitus (T2DM) but not Type 1 (T1DM), and is not due to diastolic dysfunction (#141)
5:15 PM
Timothy J Roberts
ADS Clinical Orals - Pregnancy, diet & exercise
Pulmonary microvascular disease in diabetes mellitus (DM) subjects detected by exercise echocardiography is not associated with reduced exercise capacity (#85)
9:30 AM
Timothy J Roberts
ADS President's Clinical Young Investigator Award
Functional Magnetic Resonance Imaging (MRI) changes in Type 1 Diabetes with and without Renal Hyperfiltration (#221)
2:00 PM
Jas-mine Seah
ADS Clinical Poster Award Session
The contribution of glycaemic status to the progression of kidney disease among Indigenous Australians with and without albuminuria– the eGFR follow-up study (#30)
11:00 AM
Elizabeth LM Barr
ADS Clinical Orals - Renal & Foot Complications
Tumour Necrosis Factor-alpha Receptor 1 and 2 are Reduced in patients with Type 1 Diabetes and Hyperfiltration (#34)
12:00 PM
Jas-mine Seah
ADS Clinical Orals - Renal & Foot Complications
Audit of Diabetes Management Guidelines for the Cancer Centre during the Pilot Phase (#59)
4:15 PM
Peter G Colman
ADS Clinical Orals - Type 2 Therapies
Regulation of alpha cell function and fatty acid levels by hyperinsulinaemia after islet cell transplantation in Type 1 diabetes (#166)
10:45 AM
Glenn M Ward
ADS Clinical Orals - Type 1 Diabetes